RVTY · Company research
Revvity, Inc. (RVTY): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
27records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Reit 1 (TASE:RIT1) Stock May Be Near Fair Value On Cash Flow - Yahoo Finance | Reit 1 (TASE:RIT1) Stock May Be Near Fair Value On Cash Flow Yahoo Finance | View source ↗ | Yahoo Finance | Oct 17, 2026 | neutral | 0 | 0.6 |
| Revvity, Inc. (RVTY) Stock Price, News, Quote & History - Yahoo! Finance Canada | Revvity, Inc. (RVTY) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 17, 2026 | neutral | 0 | 0.6 |
| RVTY Oct 2026 125.000 call (RVTY261016C00125000) Stock Price, News, Quote & History - Yahoo! Finance Canada | RVTY Oct 2026 125.000 call (RVTY261016C00125000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 16, 2026 | neutral | 0 | 0.6 |
| Revvity (RVTY) Gains Ahead Of Earnings, Is The Stock Too Expensive? - Simply Wall Street | Revvity (RVTY) Gains Ahead Of Earnings, Is The Stock Too Expensive? Simply Wall Street | View source ↗ | Simply Wall Street | Oct 16, 2026 | neutral | 0 | 0.6 |
| Top Revvity (RVTY) Competitors 2026 - MarketBeat | Top Revvity (RVTY) Competitors 2026 MarketBeat | View source ↗ | MarketBeat | Oct 16, 2026 | neutral | 0 | 0.6 |
| RVTY Oct 2026 115.000 put (RVTY261016P00115000) Stock Price, News, Quote & History - Yahoo! Finance Canada | RVTY Oct 2026 115.000 put (RVTY261016P00115000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 16, 2026 | neutral | 0 | 0.6 |
| RVTY Oct 2026 110.000 put (RVTY261016P00110000) Stock Price, News, Quote & History - Yahoo! Finance Canada | RVTY Oct 2026 110.000 put (RVTY261016P00110000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| Revvity (RVTY) Stock Could Be 12% Stretched On Cash Flow - Yahoo Finance | Revvity (RVTY) Stock Could Be 12% Stretched On Cash Flow Yahoo Finance | View source ↗ | Yahoo Finance | Oct 15, 2026 | neutral | 0 | 0.6 |
| Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance | Revvity, Inc. (RVTY) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 14, 2026 | neutral | 0 | 0.6 |
| Revvity, Inc. (RVTY) stock price, news, quote and history - Yahoo Finance Singapore | Revvity, Inc. (RVTY) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 14, 2026 | neutral | 0 | 0.6 |
| Avoiding Lag: Real-Time Signals in (RVTY) Movement - Stock Traders Daily | Avoiding Lag: Real-Time Signals in (RVTY) Movement Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 14, 2026 | neutral | 0 | 0.6 |
| Here's How Much $100 Invested In Revvity 15 Years Ago Would Be Worth Today - Benzinga | Here's How Much $100 Invested In Revvity 15 Years Ago Would Be Worth Today Benzinga | View source ↗ | Benzinga | Oct 13, 2026 | neutral | 0 | 0.6 |
| Thermo Fisher to Report Q3 Earnings: What's in the Cards? | Thermo Fisher Scientific is set to report Q3 2026 results on October 21, with consensus estimates projecting 7.1% revenue growth to $11.91B and 10.5% EPS growth to $6.40. The company's Life Sciences Solutions and Laboratory Products segments are expected to drive growth at 10.1% and 9.8% respectively, supported by recent product innovations. However, Specialty Diagnostics revenues are projected to decline 3% following the sale of its microbiology business to Astorg for $1.075 billion. | View source ↗ | Zacks Investment Research | Oct 13, 2026 | bullish | 0.6 | 1 |
| Thermo Fisher to Report Q3 Earnings: What's in the Cards? | Thermo Fisher Scientific is set to report Q3 2026 results on October 21, with consensus estimates projecting 7.1% revenue growth to $11.91B and 10.5% EPS growth to $6.40. The company's Life Sciences Solutions and Laboratory Products segments are expected to drive growth at 10.1% and 9.8% respectively, supported by recent product innovations. However, Specialty Diagnostics revenues are projected to decline 3% following the sale of its microbiology business to Astorg for $1.075 billion. | View source ↗ | Zacks Investment Research | Oct 13, 2026 | bullish | 0.6 | 1 |
| RVTY Oct 2026 135.000 call (RVTY261016C00135000) Stock Price, News, Quote & History - Yahoo! Finance Canada | RVTY Oct 2026 135.000 call (RVTY261016C00135000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 11, 2026 | neutral | 0 | 0.6 |
| Which S&P500 stocks are gapping on Thursday? - ChartMill | Which S&P500 stocks are gapping on Thursday? ChartMill | View source ↗ | ChartMill | Oct 8, 2026 | neutral | 0 | 0.6 |
| Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance | Revvity, Inc. (RVTY) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 8, 2026 | neutral | 0 | 0.6 |
| T. Rowe Price reports sole voting power over 12.9M shares in Revvity (RVTY). - Stock Titan | T. Rowe Price reports sole voting power over 12.9M shares in Revvity (RVTY). Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| Revvity, Inc. (RVTY) stock price, news, quote and history - Yahoo Finance Australia | Revvity, Inc. (RVTY) stock price, news, quote and history Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 2, 2026 | neutral | 0 | 0.6 |
| A planned 84-share sale leaves Revvity (RVTY) officer holding 7,117 shares directly. - Stock Titan | A planned 84-share sale leaves Revvity (RVTY) officer holding 7,117 shares directly. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock? | Revvity (RVTY), a maker of scientific instruments, has been upgraded to Zacks Rank #2 (Buy) due to rising earnings estimate revisions over the past three months. The upgrade reflects positive momentum in the company's earnings outlook, which historically correlates with near-term stock price increases. The company is expected to earn $5.36 per share for fiscal year 2026. | View source ↗ | Zacks Investment Research | Oct 2, 2026 | bullish | 1 | 1 |
| Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock? | Revvity (RVTY), a maker of scientific instruments, has been upgraded to Zacks Rank #2 (Buy) due to rising earnings estimate revisions over the past three months. The upgrade reflects positive momentum in the company's earnings outlook, which historically correlates with near-term stock price increases. The company is expected to earn $5.36 per share for fiscal year 2026. | View source ↗ | Zacks Investment Research | Oct 2, 2026 | bullish | 1 | 1 |
| Third-quarter results are due before markets open Nov. 3; Revvity's call follows at 7:30 a.m. ET. - Stock Titan | Third-quarter results are due before markets open Nov. 3; Revvity's call follows at 7:30 a.m. ET. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| RVTY Stock Price and Chart — NYSE:RVTY - TradingView | RVTY Stock Price and Chart — NYSE:RVTY TradingView | View source ↗ | TradingView | Oct 2, 2026 | neutral | 0 | 0.6 |
| Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance | Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 2, 2026 | neutral | 0 | 0.6 |
| Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - TradingView | Here's Why You Should Retain Revvity Stock in Your Portfolio for Now TradingView | View source ↗ | TradingView | Sep 29, 2026 | neutral | 0 | 0.6 |
| Why Revvity (RVTY) Stock Is Up Today - StockStory | Why Revvity (RVTY) Stock Is Up Today StockStory | View source ↗ | StockStory | Aug 5, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.